A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Assessing Efficacy and Safety of a Novel Low-Dose Turmeric Extract Formulation in Healthy Adults with Chronic Knee Pain [Corrigendum]

Thanawala S, Shah R, Somepalli V, Alluri KV, Desomayanandam P, Bhuvanendran A. Clin Pharmacol. 2021;13:91–100. The authors have informed the journal that on page 93, Table 2 “Efficacy Endpoints”, for the primary endpoint “Visual analogue scale after 80-m fast-paced walk test”, the parameter “Change from B to D45” is erroneously mentioned as −1.5 ± 0.4 where it should be −1.0 ± 0.4. The correct Table 2 is: On page 96, Table 3 “Biochemical and Inflammatory Markers”, for C-reactive protein, the unit is erroneously mentioned as (mg/dL), where it should be (mg/L). The correct Table 3 is: The authors advise these errors/corrections will not affect the previously shown results/conclusions and apologize for any confusion this may have caused. Table 2 Efficacy Endpoints Table 3 Biochemical and Inflammatory Marker